Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET

  1. Garcia-Moure, M.
  2. Gonzalez-Huarriz, M.
  3. Labiano, S.
  4. Guruceaga, E.
  5. Bandres, E.
  6. Zalacain, M.
  7. Marrodan, L.
  8. de Andrea, C.
  9. Villalba, M.
  10. Martinez-Velez, N.
  11. Laspidea, V.
  12. Puigdelloses, M.
  13. Perez-Larraya, J.G.
  14. Iñigo-Marco, I.
  15. Stripecke, R.
  16. Chan, J.A.
  17. Raabe, E.H.
  18. Kool, M.
  19. Gomez-Manzano, C.
  20. Fueyo, J.
  21. Patiño-García, A.
  22. Alonso, M.M.
Aldizkaria:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Argitalpen urtea: 2021

Alea: 27

Zenbakia: 6

Orrialdeak: 1807-1820

Mota: Artikulua

DOI: 10.1158/1078-0432.CCR-20-3313 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus